Sixty degrees pharmaceuticals announces patent license agreement to advance development of tafenoquine for babesiosis treatment and prevention with yale school of medicine and yale school of public health

60 degrees pharma partners with yale to develop tafenoquine for treating and preventing babesiosis, a severe tick-borne disease with limited treatments.

SXTP Ratings Summary

SXTP Quant Ranking